Archiv SCREENING

Globalization Needs Local Proximity

A. Seidinger

Seite 01

Screening Europe 2005

A Breath of Fresh Air

Seite 07

From Targets to Candidates

The Society for Biomolecular Screening

Seite 07

Pharma R&D in China

G. Festel, Festel Capital, Huenenberg/Zug, Switzerland

Seite 010

In Silico ADME

From QSAR to Systemic Pharmacokinetic Modelling

F. Yamashita, Kyoto University, Japan

Seite 012

Cancer Nanotechnology: Bioconjugated Nanoparticles for Targeted Drug Delivery

G. J. Kim, S. Nie, Emory University and Georgia Institute of Technology, Atlanta, USA

Seite 014

Zebrafish: a High Biological Value Screening Platform

D. R. Love et al., University of Auckland, New Zealand

Seite 017

MSI in Small (and Very Small) Animals

N. S. Trede, Huntsman Cancer Institute, Salt Lake City, USA; R. M. Levenson, CRI Inc., Woburn, USA

Seite 020

Strategies and Tools for Computational Systems Biology

J. M. Rohwer, Stellenbosch University, Matieland, South Africa

Seite 023

Vertical Genomics and the Dynamics of Cell Signalling

S. Nagl, University College London, UK

Seite 026

Membrane Protein Production: a Bacterial "Factory” in Rhodobacter

P: D. Laible et al., Argonne National Laboratory, IL, USA

Seite 030

Toponomics

A Novel Approach to Identify Combinatorial Biomarkers in situ

R. Koop, MelTec, Magdeburg, Germany

Seite 032

Successful Biopharmaceutical Discovery

S. Clulow, Cambridge Antibody Technology, Cambridge, UK

Seite 034

Microarray Technology Platforms and Drug Discovery

G. Hardiman, University of California, San Diego, USA

Seite 038

Cloning and Expression

Tailor-made Solutions for your Project

Trenzyme, Konstanz, Germany

Seite 041

Using Comprehensive Metabolomics to Identify Novel Biomarkers

K. M. Weinberger, A. Graber, Biocrates Life Sciences, Innsbruck, Austria

Seite 042

Respirometric Screening Technology (RST)

D. Papkovsky, Luxcel Biosciences, Cork, Ireland

Seite 046